Local response and impact on survival after local ablation of liver metastases from colorectal carcinoma by computed tomography-guided high-dose-rate brachytherapy

International Journal of Radiation Oncology Biology Physics

Volumn 78, Issue 2, 2010, Pages 479-485

  Ricke, Jens ^a   Mohnike, Konrad ^a   Pech, MacIej ^a   Seidensticker, Max ^a   Rühl, Ricarda ^a   Wieners, Gero ^a   Gaffke, Gunnar ^a   Kropf, Siegfried ^a   Felix, Roland ^b   Wust, Peter ^b  

^a UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Brachytherapy; Colorectal carcinoma; Liver metastases; Local ablation

Indexed keywords

ANTI-TUMORS; BRACHYTHERAPY; COLORECTAL CANCER; COLORECTAL CARCINOMA; COMPUTED TOMOGRAPHY; CROSS-OVER; CYTOREDUCTION; DOSE DEPENDENCY; DOSE LEVELS; HIGH RATE; HIGH-DOSE RATE BRACHYTHERAPY; LIVER METASTASES; LIVER METASTASIS; LOCAL ABLATION; LOCAL RECURRENCE; LOCAL RESPONSE; LOCAL TUMOR ABLATION; LOCAL TUMOR CONTROL; MEDIAN DIAMETERS; MINIMALLY INVASIVE; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; SAFETY CONSTRAINT; TUMOR LESIONS;

COMPUTERIZED TOMOGRAPHY; LIVER; ONCOLOGY; PATHOLOGY; RADIOTHERAPY; TUMORS;

ABLATION;

ANTINEOPLASTIC AGENT; IRIDIUM;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; HUMAN; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSPECTIVE PAYMENT; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RANDOMIZED CONTROLLED TRIAL; TUMOR ABLATION; ANALYSIS OF VARIANCE; COLORECTAL TUMOR; COMPLICATION; COMPUTER ASSISTED RADIOTHERAPY; DISEASE COURSE; DISEASE FREE SURVIVAL; LIVER NEOPLASMS; MIDDLE AGED; MORTALITY; PATHOLOGY; PHASE 3 CLINICAL TRIAL; PROSPECTIVE STUDY; RADIATION INJURY; RADIATION RESPONSE; SECONDARY; TUMOR RECURRENCE; TUMOR VOLUME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BRACHYTHERAPY; COLORECTAL NEOPLASMS; CROSS-OVER STUDIES; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; IRIDIUM RADIOISOTOPES; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, COMPUTER-ASSISTED; TOMOGRAPHY, X-RAY COMPUTED; TUMOR BURDEN;

EID: 77954087107     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.09.026     Document Type: Article

References (24)

1. H. Hurwitz, L. Fehrenbacher, and W. Novotny Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer N Engl J Med 350 2004 2335 2342
2. B.J. Giantonio, D.E. Levy, and P.J. O'Dwyer A phase II study of high-dose bevacizumab in combination with irinotecan, 5-fluorouracil, leucovorin, as initial therapy for advanced colorectal cancer: Results from the Eastern Cooperative Oncology Group study E2200 Ann Oncol 17 2006 1399 1403
3. D. Cunningham, Y. Humblet, and S. Siena Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer N Engl J Med 351 2004 337 345
4. A. Jemal, R. Siegel, and E. Ward Cancer statistics, 2008 CA Cancer J Clin 58 2008 71 96
5. G. Steele, and T.S. Ravikumar Resection of hepatic metastases from colorectal cancer: Biologic perspective Ann Surg 210 1989 127 138
6. J. Norstein, and W. Silen Natural history of liver metastases from colorectal carcinoma J Gastrointest Surg 1 1997 398 407
7. W. Silen Hepatic resection for metastases from colorectal carcinoma is of dubious value Arch Surg 124 1989 1021 1022
8. M.A. Adson Resection of liver metastases - when is it worthwhile? World J Surg 11 1987 511 520
9. G. Yothers Toward progression-free survival as a primary end point in advanced colorectal cancer J Clin Oncol 25 2007 5153 5154
10. S.N. Goldberg, C.J. Grassi, and J.F. Cardella Image-guided tumor ablation: Standardization of terminology and reporting criteria J Vasc Interv Radiol 16 2005 765 778
11. Y.Y. Xiao, J.L. Tian, and J.K. Li CT-guided percutaneous chemical ablation of adrenal neoplasms AJR Am J Roentgenol 190 2008 105 110
12. A.R. Gillams, and W.R. Lees Radiofrequency ablation of lung metastases: Factors influencing success Eur Radiol 18 2009 672 677
13. S.A. Curley Radiofrequency ablation versus resection for resectable colorectal liver metastases: Time for a randomized trial? Ann Surg Oncol 15 2008 11 13
14. Y.J. Zhang, H.H. Liang, and M.S. Chen Hepatocellular carcinoma treated with radiofrequency ablation with or without ethanol injection: A prospective randomized trial Radiology 244 2007 599 607
15. T.J. Vogl, R. Straub, and K. Eichler Colorectal carcinoma metastases in liver: Laser-induced interstitial thermotherapy-local tumor control rate and survival data Radiology 230 2004 450 458 (Pubitemid 38133806)
16. J. Ricke, P. Wust, and A. Stohlmann CT-guided interstitial brachytherapy of liver malignancies alone or in combination with thermal ablation: Phase I-II results of a novel technique Int J Radiat Oncol Biol Phys 58 2004 1496 1505
17. J. Ricke, P. Wust, and G. Wieners Liver malignancies: CT-guided interstitial brachytherapy in patients with unfavorable lesions for thermal ablation J Vasc Interv Radiol 15 2004 1279 1286 (Pubitemid 39487859)
18. G. Wieners, M. Pech, and M. Rudzinska CT-guided interstitial brachytherapy in the local treatment of extrahepatic, extrapulmonary secondary malignancies Eur Radiol 16 2006 2586 2593
19. L. Dawson, and D. Jaffray Advances in image guided radiation therapy J Clin Oncol 25 2007 938 946
20. H. Shirato, S. Shimizu, and K. Kitamura Four-dimensional treatment planning and fluoroscopic real-time tumor tracking radiotherapy for moving tumor Int J Radiat Oncol Biol Phys 48 2000 435 442
21. J. Ricke, M. Seidensticker, and L. Lüdemann In vivo assessment of the tolerance dose of small liver volumes after single-fraction HDR irradiation Int J Radiat Oncol Biol Phys 62 2005 776 784
22. F.K. Welsh, P.P. Tekkis, and T. ÓRourke Quantification of risk of a positive (R1) resection margin following hepatic resection for metastatic colorectal cancer: An aid to clinical decision-making Surg Oncol 17 2008 3 13
23. K. Shirabe, K. Takenaka, and T. Gion Analysis of prognostic risk factors in hepatic resection for metastatic colorectal carcinoma with special reference to the surgical margin Br J Surg 84 1997 1077 1080
24. N. Yokoyama, Y. Shirai, and Y. Ajioka Immunohistochemically detected hepatic micrometastases predict a high risk of intrahepatic recurrence after resection of colorectal carcinoma liver metastases Cancer 94 2002 1642 1647